Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
J Med Chem. 2023 Dec 14;66(23):16388-16409. doi: 10.1021/acs.jmedchem.3c01848. Epub 2023 Nov 22.
Modulating the chemical composition of cereblon (CRBN) binders is a critical step in the optimization process of protein degraders that seek to hijack the function of this E3 ligase. Small structural changes can have profound impacts on the overall profile of these compounds, including depth of on-target degradation, neosubstrate degradation selectivity, as well as other drug-like properties. Herein, we report the design and synthesis of a series of novel CRBN binding moieties. These CRBN binders were evaluated for CRBN binding and degradation of common neosubstrates Aiolos and GSPT1. A selection of these binders was employed for an exploratory matrix of heterobifunctional molecules, targeting CRBN-mediated degradation of the androgen receptor.
调节 cereblon(CRBN)结合物的化学组成是优化蛋白降解剂的关键步骤,这些降解剂旨在劫持这种 E3 连接酶的功能。小的结构变化会对这些化合物的整体特性产生深远的影响,包括靶标降解的深度、新底物降解的选择性以及其他类似药物的特性。在此,我们报告了一系列新型 CRBN 结合物的设计和合成。评估了这些 CRBN 结合物与常见新底物 Aiolos 和 GSPT1 的 CRBN 结合和降解。选择了其中一些结合物用于探索性的杂双功能分子矩阵,以靶向 CRBN 介导的雄激素受体降解。